Secondary Cytoreduction Versus Chemotherapy Alone in the Treatment of Patients with Recurrent Ovarian Cancer: Is a Randomized Trial Worthwhile?

被引：0
|
作者：
Paolo Sammartino
Daniele Biacchi
Marialuisa Framarino
机构：
[1] Sapienza University of Rome,Department of Surgery “Pietro Valdoni”
[2] Sapienza University of Rome,Department of Gynecology and Obstetrics
来源：
Current Oncology Reports | 2013年 / 15卷
关键词：
Ovarian Cancer; Ovarian Carcinoma; Cytoreductive Surgery; Late Development; Cytogenetic Study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：191 / 191
相关论文
共 50 条
  • [1] Secondary Cytoreduction Versus Chemotherapy Alone in the Treatment of Patients with Recurrent Ovarian Cancer: Is a Randomized Trial Worthwhile?
    Sammartino, Paolo
    Biacchi, Daniele
    Framarino, Marialuisa
    CURRENT ONCOLOGY REPORTS, 2013, 15 (03) : 191 - 191
  • [2] Secondary Cytoreduction Versus Chemotherapy Alone in the Treatment of Patients with Recurrent Ovarian Cancer: Is a Randomized Trial Worthwhile? Reply
    Harter, Philipp
    Heitz, Florian
    du Bois, Andreas
    CURRENT ONCOLOGY REPORTS, 2013, 15 (03) : 192 - 192
  • [3] Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis
    Bonvalot, S
    Cavalcanti, A
    Le Péchoux, C
    Terrier, P
    Vanel, D
    Blay, JY
    Le Cesne, A
    Elias, D
    EJSO, 2005, 31 (08): : 917 - 923
  • [4] Secondary cytoreduction for patients with recurrent ovarian cancer
    Díaz-Montes T.P.
    Bristow R.E.
    Current Oncology Reports, 2005, 7 (6) : 451 - 458
  • [5] Secondary cytoreduction for recurrent ovarian cancer
    Park, SY
    PROCEEDINGS OF THE XIX ASIAN AND OCEANIC CONGRESS OF OBSTETRICS & GYNECOLOGY, 2005, : 127 - 135
  • [6] LAPAROSCOPIC SECONDARY CYTOREDUCTION AND HYPERTHERMIA INTRAPERITONEAL CHEMOTHERAPY FOR RECURRENT OVARIAN CANCER
    Naki, M. M.
    Karabuk, E.
    Alkhan, F.
    Gungor, M.
    Kose, M. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1402 - 1402
  • [7] Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
    Coleman, Robert L.
    Spirtos, Nick M.
    Enserro, Danielle
    Herzog, Thomas J.
    Sabbatini, Paul
    Armstrong, Deborah K.
    Kim, Jae-Weon
    Park, Sang-Yoon
    Kim, Byoung-Gie
    Nam, Joo-Hyun
    Fujiwara, Keiichi
    Walker, Joan L.
    Casey, Ann C.
    Alvarez Secord, Angeles
    Rubin, Steve
    Chan, John K.
    DiSilvestro, Paul
    Davidson, Susan A.
    Cohn, David E.
    Tewari, Krishnansu S.
    Basen-Engquist, Karen
    Huang, Helen Q.
    Brady, Mark F.
    Mannel, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (20): : 1929 - 1939
  • [8] Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
    Coleman, Robert L.
    Spirtos, Nick M.
    Enserro, Danielle
    Herzog, Thomas J.
    Sabbatini, Paul
    Armstrong, Deborah K.
    Kim, Jae-Weon
    Park, Sang-Yoon
    Kim, Byoung-Gie
    Nam, Joo-Hyun
    Fujiwara, Keiichi
    Walker, Joan L.
    Casey, Ann C.
    Secord, Angeles Alvarez
    Rubin, Steve
    Chan, John K.
    DiSilvestro, Paul
    Davidson, Susan A.
    Cohn, David E.
    Tewari, Krishnansu S.
    Basen-Engquist, Karen
    Huang, Helen Q.
    Brady, Mark F.
    Mannel, Robert S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (03) : 165 - 166
  • [9] Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
    Sharma, Vinod
    Naik, Ramavath D.
    Vanidassane, Ilavarasi
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (07): : 685 - 685
  • [10] Secondary Surgery Versus Chemotherapy for Recurrent Ovarian Cancer
    Bickell, Nina A.
    Egorova, Natalia
    Prasad-Hayes, Monica
    Franco, Rebeca
    Howell, Elizabeth A.
    Wisnivesky, Juan
    Deb, Partha
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (05): : 458 - 464
12345